iTHRIV Awards $200,000 to Pediatric, Prenatal and Cancer Research
12/6/2022
The integrated Translational Health Research Institute of Virginia (iTHRIV), a National Institutes of Health (NIH)-funded Clinical and Translational Science Award hub, has awarded $200,000 in pilot funding across four multi-institutional research…
Wladek Minor, PhD and Team’s Discovery Challenges Key Principle Used in Development of New Drugs
12/6/2022
A surprising discovery from the University of Virginia School of Medicine has torpedoed a key principle used in the development of new drugs to treat diseases. The finding could speed the…
School of Medicine Publishes 2022 Annual Report
12/6/2022
The University of Virginia School of Medicine 2022 Annual Report was distributed to alumni, SOM faculty, and top-rated SOM deans and leadership across the U.S. in December. The report is…
iTHRIV Leaders Attend Clinical Translational Science Award Program Meeting
11/29/2022
In early November, members of iTHRIV’s leadership team attended the 2022 Clinical Translational Science Award (CTSA) Program Meeting. UVA’s Karen Johnston MD, MSc and Sandra Burks, RN were joined by…
NIH Policy for Data Management and Sharing Effective January 25, 2023
11/29/2022
NIH has issued a final Policy for Data Management and Sharing (DMS Policy) to promote the management and sharing of scientific data generated from NIH-funded or conducted research. This policy…
iTHRIV Backs Community-Based Research Projects with $80K in Seed Grants
11/29/2022
The integrated Translational Health Research Institute of Virginia, or iTHRIV, a National Institutes of Health-funded Clinical and Translational Science Award hub, has awarded almost $80,000 in seed funding to two community-focused projects focused…
11/29/2022
UVA School of Medicine researchers have developed an important new tool to help scientists sort signal from noise as they probe the genetic causes of cancer and other diseases. In…
11/8/2022
Firas El Chaer, MD, an assistant professor of medicine who specializes in hematology and oncology, will present preliminary clinical data evaluating investigational agent TP-3654 at the 64th American Society of…
